Comparative seroprevalence of hepatitis A and E viruses in blood donors from Wielkopolska region, west-central Poland

• Autorzy: Bura M. , Lagiedo-Zelazowska M. , Michalak M. , Sikora J. , Mozera-Lisewska I.
• Języki publikacji: EN

Abstrakty

EN

The objective of the present study was to investigate the seroprevalence of HAV and HEV in Polish blood donors (BDs). One hundred and ten randomly selected healthy BDs, living in Wielkopolska Region were tested for anti-HAV IgG and anti-HEV IgG with commercial assays. The seroprevalence of anti-HAV was 11.8%; anti-HEV were detected in 60.9% of BDs (p < 0.0001). Consumption of risky food was more common in anti-HEV-positive BDs (59.1% vs. 33.3%; p = 0.01). Twelve out of 20 BDs (60%) with no history of travel abroad were exposed to HEV. Wielkopolska Region, Poland should be regarded as a new HEV infection-hyperendemic area in Europe.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2018
• Tom: 67
• Numer: 1
• Opis fizyczny: p.113-115,ref.

Twórcy

autor

Bura M.

• Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Poznan, Poland

autor

Lagiedo-Zelazowska M.

• Chair of Clinical Immunology, Department of Immunology, Poznan University of Medical Sciences, Poznan, Poland

autor

Michalak M.

• Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland

autor

Sikora J.

• Chair of Clinical Immunology, Department of Immunology, Poznan University of Medical Sciences, Poznan, Poland

autor

Mozera-Lisewska I.

• Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Poznan, Poland

Bibliografia

• Bendall R., V. Ellis, S. Ijaz, R. Ali and H. Dalton. 2010. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J. Med. Virol. 82: 799–805.
• Bura M., M. Michalak, M. Chojnicki, A. Czajka, A. Kowala-Piaskowska and I. Mozer-Lisewska. 2015. Seroprevalence of anti-HEV IgG in 182 Polish patients. Postepy Hig. Med. Dosw. 69: 320–326.
• Dreier J. and Juhl D. 2014. Autochthonous hepatitis E virus infections: a new transfusion-associated risk? Transfus. Med. Hemother. 41: 29–39.
• European Centre for Disease Prevention and Control. 2014. Annual epidemiological report 2014 – food- and waterborne diseases and zoonoses. http://ecdc.europa.eu/en/publications/Publications/food-waterborne-diseases-annual-epidemiological-report- 2014.pdf, 2017.01.05
• Guillois Y., F. Abravanel, T. Miura, N. Pavio, V. Vaillant, S. Lhomme, F.S. Le Guyader, N. Rose, J.C. Le Saux, L.A. King and others. 2016. High proportion of asymptomatic infections in an outbreak of hepatitis E associated with a spit-roasted piglet, France, 2013. Clin. Infect. Dis. 62: 351–357.
• Hewitt P.E., S. Ijaz, S.R. Brailsford, R. Brett, S. Dicks, B. Haywood, I.T. Kennedy, A. Kitchen, P. Patel, J. Poh and others. 2014. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 384: 1766–1773.
• Huzly D., M. Umhau, D. Bettinger, T. Cathomen, F. Emmerich, P. Hasselblatt, H. Hengel, R. Herzog, O. Kappert, S. Maassen and others. 2014. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill. 19: 21.
• Lapa D., M.R. Capobianchi and A.R. Garbuglia. 2015. Epidemiology of hepatitis E virus in European countries. Int. J. Mol. Sci. 16: 25711–25743.
• Magdzik W. and M.P. Czarkowski. 2004. Changes in endemicity of hepatitis A in Poland (in Polish). Przegl. Epidemiol. 58: 3–8.
• Mansuy J.M., R. Bendall, F. Legrand-Abravanel, K. Sauné,M. Miédouge, V. Ellis, H. Rech, F. Destruel, N. Kamar, H.R. Dalton and others. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg. Infect. Dis. 17: 2309–2312.
• Matsubayashi K., Y. Nagaoka, H. Sakata, S. Sato, K. Fukai, T. Kato, K. Takahashi, S. Mishiro, M. Imai, N. Takeda and others. 2004. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 44: 934–940.
• Meng X.J. 2013. Zoonotic and foodborne transmission of hepatitis E virus. Semin. Liver. Dis. 33: 41–49.
• Sadkowska-Todys M., A. Baumann-Popczyk, N. Wnukowska, B. Popczyk, B. Kucharczyk and E. Gołąb. 2015. Occurence and prevalence of selected zoonotic agents: Echinococcus multilocularis, Trichinella spiralis and hepatitis E virus (HEV) in the population of Polish hunters – results of the study conducted in 2010–2012. Przegl. Epidemiol. 69: 673–678.
• Said B., S. Ijaz, G. Kafatos, L. Booth, H.L. Thomas, A. Walsh, M. Ramsay and D. Morgan; Hepatitis E Incident Investigation Team. 2009. Hepatitis E outbreak on cruise ship. Emerg. Infect. Dis. 15: 1738–1744.
• Wenzel J.J., J. Preiss, M. Schemmerer, G. Huber and W. Jilg. 2013. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J. Infect. Dis. 207: 497–500.

Identyfikatory

DOI

10.5604/01.3001.0011.6151